Satellos Bioscience Inc (MSCLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,206 | 1,480 | 2,399 | 1,512 | 2,192 |
| Marketable Securities | 1 | 2 | N/A | N/A | N/A |
| Receivables | 48 | 200 | 162 | 166 | 440 |
| TOTAL | $2,279 | $1,717 | $2,606 | $1,696 | $2,651 |
| Non-Current Assets | |||||
| PPE Net | 5 | 6 | 7 | 6 | 7 |
| Investments And Advances | 31 | 32 | 0 | 0 | 0 |
| Intangibles | 2,895 | 3,012 | 5,220 | 5,421 | 5,550 |
| TOTAL | $2,931 | $3,051 | $5,227 | $5,427 | $5,557 |
| Total Assets | $5,210 | $4,768 | $7,833 | $7,122 | $8,208 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 136 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,138 | 2,177 | 1,546 | 1,631 | 1,239 |
| TOTAL | $2,274 | $2,177 | $1,546 | $1,631 | $1,239 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,363 | N/A | N/A | N/A | N/A |
| TOTAL | $1,363 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,637 | $2,177 | $1,546 | $1,631 | $1,239 |
| Shareholders' Equity | |||||
| Common Shares | 22,498 | 23,237 | 23,152 | 22,174 | 22,358 |
| Retained earnings | -24,600 | -24,317 | -20,336 | -19,298 | -17,693 |
| Other shareholders' equity | 1,550 | 1,614 | -1 | 0 | -3 |
| TOTAL | $1,573 | $2,591 | $6,287 | $5,491 | $6,969 |
| Total Liabilities And Equity | $5,210 | $4,768 | $7,833 | $7,122 | $8,208 |